Who owns Elgydium?
Elgydium is owned by Pierre Fabre (France).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Laboratoires Pierre Fabre — 2025 Annual Report: Leading the way, everywhere. Last checked .
Key facts
- Current owner
- Laboratoires Pierre Fabre S.A. reported
- Owner HQ
- 🇫🇷 France, Castres
- Origin
- 🇫🇷 France
- Category
- Personal care & beauty › Oral care › Toothpaste & toothbrushes
- Last verified
- · 1 sources
About Elgydium
Elgydium is the toothpaste and oral hygiene range of Pierre Fabre Oral Care, sold in pharmacies and developed with dental practitioners over more than fifty years. Its products are positioned by problem — plaque, sensitivity, whitening, gum care — rather than by flavour, and in a 2024 survey of 270 French dentists 53 per cent said they recommended the brand. Sensiprotect, for sensitive teeth, was its 2025 launch.
Ownership timeline of Elgydium
- Current owner Pierre Fabre [1] reported
Where Elgydium sits in Pierre Fabre
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Pierre Fabre ownership tree →
See the full Pierre Fabre brand portfolio (9) →
Other brands owned by Pierre Fabre
Pierre Fabre controls 9 brands on Brandtree, 9 of them in personal care & beauty.
Also in personal care & beauty
Other brands in toothpaste & toothbrushes, and who owns them
The 42 brands in toothpaste & toothbrushes on Brandtree belong to 23 owners. The largest is Colgate-Palmolive, with 5; Pierre Fabre has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Colgate | Colgate-Palmolive | 🇺🇸 United States |
| Desensin | Dentaid | 🇪🇸 Spain |
| Close-Up | Unilever | 🇬🇧 United Kingdom |
| Parodontax | Haleon | 🇬🇧 United Kingdom |
| Pepsodent (United States) | Church & Dwight | 🇺🇸 United States |
| Bioniq | Dr. Wolff Group | 🇩🇪 Germany |
| CLINICA | Lion | 🇯🇵 Japan |
| Crest | Procter & Gamble | 🇺🇸 United States |
About the owner: Pierre Fabre
Pierre Fabre is a privately held company headquartered in Castres, France, founded in 1962. Brandtree records 9 brands under its control.
Pierre Fabre is a French pharmaceutical and dermo-cosmetics group founded in 1962 by Pierre Fabre, a pharmacist with a passion for botany who turned his dispensary in the Tarn into an international company. It reported revenue of €3.2 billion in 2025, split between €1.7 billion of dermo-cosmetics and €1.4 billion of medicines, with 71 per cent earned outside France and products sold in 130 territories. Its ownership is unusual: the Fondation Pierre Fabre, a government-recognised public-interest foundation created in 1999, is the majority shareholder with 86 per cent, and the company's own employees are the second-largest shareholder, 6,625 of them by the end of 2025.
Pierre Fabre: full profile, brands and acquisition history →
🇫🇷 Elgydium and other French brands
Brandtree records a controlling owner for 318 brands that began in France. 99 of them (31%) are now controlled by a company headquartered in another country; Elgydium is not one of them.
- Axe — Unilever 🇬🇧
- BIC Razors — BIC 🇫🇷
- Bioderma — NAOS 🇫🇷
- Botot — Bolton Group 🇮🇹
- Chanel No. 5 — Chanel 🇬🇧
- Darphin — Estée Lauder 🇺🇸
Frequently asked questions
Who is the parent company of Elgydium?
The parent company of Elgydium is Pierre Fabre, a privately held company headquartered in France.
Is Elgydium French?
Yes. Elgydium originated in France and its owner, Pierre Fabre, is also headquartered in France.
Is Elgydium still owned by Pierre Fabre?
Yes. As of 28 September 2026, Elgydium is still owned by Pierre Fabre. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Laboratoires Pierre Fabre — 2025 Annual Report: Leading the way, everywhere — Laboratoires Pierre Fabre, Annual report; retrieved 28 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.